서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 20 of 20

Issue DateTitle / Author(s) / CitationFileAltmetrics
2007-08
A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells
DOI
2009-05
Upregulation of Beclin-1 expression and phosphorylation of Bcl-2 and p53 are involved in the JNK-mediated autophagic cell death

Park, Kyung-Jin; Lee, Seung-Hyun; Lee, Chang-Han; Jang, Ji-Young; Kwon, Myung-Hee; Kim, Yong-Sung; Chung, Junho

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; Vol.382(4); 726-729

DOI
2016-12
Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination
DOI
2018-05
Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node
DOI
2019-03
An engineered human fc variant with exquisite selectivity for FcγRIIIaV158 reveals that ligation of FcγRIIIa mediates potent antibody dependent cellular phagocytosis with GM-CSF-differentiated macrophages
DOI
2019-11
An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence
DOI
2020-03
Computer-based engineering of thermostabilized antibody fragments
DOI
2020-10
Tumor-associated myeloid cells provide critical support for T-ALL
DOI
2021-07
Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
DOI
2022-03
Hyperglycemia-induced oxidative stress promotes tumor metastasis by upregulating vWF expression in endothelial cells through the transcription factor GATA1
DOI
2022-03
Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity
DOI
2022-05
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
DOI
2022-08
The acidic tumor microenvironment enhances PD-L1 expression via activation of STAT3 in MDA-MB-231 breast cancer cells
view filelink
2022-09
Persistent Antibody Responses Up to 18 Months After Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection
DOI
2022-11
Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer
DOI
2022-12
Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model
view filelink
2023-02
Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naïve individuals
DOI
2023-03
Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19
DOI
2023-11
Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories
DOI
2024-02
Clinical outcomes and immunological features of COVID-19 patients receiving B-cell depletion therapy during the Omicron era
DOI
1